Background: A small randomized controlled trial suggested that dabigatran may be as
effective as warfarin in the treatment of cerebral venous thrombosis (CVT). We aimed to …

Organisation mondiale de la Santé 2022 Certains droits réservés. La présente œuvre est
disponible sous la licence Creative Commons Attribution Pas d'utilisation commerciale …

Abstract Purpose of Review Cerebral venous thrombosis (CVT) is a rare cause of stroke that
most commonly affects younger women. Here, we review new literature relevant to the …

Cerebral venous thrombosis is a rare cause of stroke in young mostly female adults which is
frequently overlooked due to its variable clinical and radiological presentation. This review …

BACKGROUND: Emerging data suggest that direct oral anticoagulants may be a suitable
choice for anticoagulation for cerebral venous thrombosis (CVT). However, conducting high …

OBJECTIVE Cerebral venous thrombosis (CVT), thrombosis of the dural sinus, cerebral
veins, or both, is a rare cerebrovascular disease. Although mortality rates after CVT have …

Cerebral venous thrombosis (CVT) is a rare form of stroke that often affects younger age
groups, especially reproductive age group females. CVT is a potentially fatal neurological …

Cerebral venous sinus thrombosis (CVST) is an uncommon venous thromboembolic event
accounting for less than 1% of strokes resulting in brain parenchymal injuries. Diagnosis …

The evolution of the Coronavirus Disease-2019 pandemic and its vaccination raised more
attention to cerebral venous thrombosis (CVT). Although CVT is less prevalent than arterial …

Vitamin K antagonists (VKAs) are the standard oral anti‐coagulant treatment for patients with
cerebral venous thrombosis (CVT). However, the direct oral anti‐coagulants (DOACs) …